We are a biotech company developing treatments for advanced-stage skin cancer. Our non-invasive investigational therapies are designed to destroy solid tumors and metastatic cancer and preserve quality of life.

OncoSec_ImmunoPulse_new

IMMUNOPULSE

FIGHTING CANCER WITH THE BODY’S IMMUNE SYSTEM

Using DNA IL-12, ImmunoPulse is designed to stimulate the body’s immune system and enable it to recognize, target, and destroy cancerous cells.

 

Download our Investor Overview:

Subscribe to Our Newsletter.

Subscribe to Our Newsletter:


Be the first to hear about new progress and breakthroughs at OncoSec.